# OnCo record mtx-531 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/mtx-531/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "mtx-531" ;
  schema:name "MTX-531"@en ;
  schema:description "MTX-531 is an experimental small molecule from MEKanistic Therapeutics, in phase 1 trials for head and neck squamous cell carcinoma, endometrial cancer and HER2-negative metastatic breast cancer and other cancers."@en ;
  schema:url <https://onco.cc/drugs/mtx-531/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/api/v2/studies/NCT07874880>, <https://www.mekanistic.com/pipeline.html>, <https://www.mekanistic.com/>, <https://clinicaltrials.gov/search?intr=MTX-531> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Small molecule (oral)" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:targets <https://onco.cc/targets/egfr/> ;
  onco:companies <https://onco.cc/companies/mekanistic-therapeutics/> ;
  onco:trials <https://onco.cc/trials/nct07874880/> .